Cournil Amandine, Kouanfack C., Eymard-Duvernay Sabrina, Lem S., Mpoudi-Ngole M., Omgba P., Tchokonte S., Mbesse G. E., Mpoudi-Ngole E., Calmy A., Delaporte Eric. (2018). Dolutegravir-versus an efavirenz 400 mg-based regimen for the initial treatment of HIV-infected patients in Cameroon : 48-week efficacy results of the NAMSAL ANRS 12313 trial [O342]. Journal of the International Aids Society, 21 (No spécial S8), HIV Glasgow, Glasgow (GBR), 2018/10/28-31. ISSN 1758-2652.
Titre du document
Dolutegravir-versus an efavirenz 400 mg-based regimen for the initial treatment of HIV-infected patients in Cameroon : 48-week efficacy results of the NAMSAL ANRS 12313 trial [O342]
Cournil Amandine, Kouanfack C., Eymard-Duvernay Sabrina, Lem S., Mpoudi-Ngole M., Omgba P., Tchokonte S., Mbesse G. E., Mpoudi-Ngole E., Calmy A., Delaporte Eric
Source
Journal of the International Aids Society, 2018,
21 (No spécial S8), ISSN 1758-2652